ZVRA · Zevra Therapeutics, Inc. · Documents
$10.25
-0.08 (-0.77%)
At close · Oct 23
Return incl. dividend (before tax)
Market Cap
$614.03M
Shares
59.38M
Volume · Oct 22
537.3K
Avg daily vol (3M)
1.05M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| DEFA14A | — | 2023-02-27 | — | |
| 8-K | — | 2023-02-24 | 2023-02-21 | |
| 8-K | — | 2023-01-25 | 2023-01-24 | |
| 8-K | — | 2023-01-20 | — | |
| 8-K | — | 2023-01-09 | 2023-01-06 | |
| 8-K | — | 2022-11-29 | 2022-11-28 | |
| 8-K | — | 2022-11-18 | — | |
| 10-Q | — | 2022-11-10 | 2022-09-30 | |
| 8-K | — | 2022-11-09 | — | |
| 10-Q | — | 2022-08-12 | 2022-06-30 | |
| 8-K | — | 2022-08-11 | — | |
| 8-K | — | 2022-07-01 | 2022-06-28 | |
| 8-K | — | 2022-06-17 | 2022-06-14 | |
| DEFA14A | — | 2022-06-17 | — | |
| 8-K | — | 2022-06-01 | 2022-05-31 | |
| 8-K | — | 2022-05-16 | 2022-05-15 | |
| DEF 14A | — | 2022-05-12 | 2022-06-28 | |
| 8-K | — | 2022-05-12 | — | |
| DEFA14A | — | 2022-05-12 | — | |
| 10-Q | — | 2022-05-12 | 2022-03-31 | |
| 10-K | — | 2022-03-31 | 2021-12-31 | |
| 8-K | — | 2022-03-30 | — | |
| 8-K | — | 2022-03-21 | — | |
| 8-K | — | 2022-03-16 | — | |
| 8-K | — | 2022-02-22 | — | |
| 8-K | — | 2022-01-19 | — | |
| 8-K | — | 2021-12-20 | — | |
| 8-K | — | 2021-12-14 | — | |
| 8-K | — | 2021-11-10 | 2021-11-05 | |
| 10-Q | — | 2021-11-10 | 2021-09-30 | |
| 8-K | — | 2021-10-19 | — | |
| 8-K | — | 2021-08-18 | — | |
| 10-Q | — | 2021-08-13 | 2021-06-30 | |
| 8-K | — | 2021-08-12 | — | |
| 8-K | — | 2021-07-21 | — | |
| S-3 | — | 2021-07-02 | — | |
| 8-K | — | 2021-07-02 | — | |
| S-3 | — | 2021-06-25 | — | |
| 8-K | — | 2021-06-24 | 2021-06-17 | |
| 8-K | — | 2021-06-23 | 2021-06-18 | |
| 8-K | — | 2021-06-16 | — | |
| 10-Q | — | 2021-05-14 | 2021-03-31 | |
| 8-K | — | 2021-05-13 | — | |
| DEFA14A | — | 2021-04-30 | — | |
| DEF 14A | — | 2021-04-30 | 2021-06-17 | |
| 8-K | — | 2021-04-08 | — | |
| 10-K | — | 2021-03-12 | 2020-12-31 | |
| 8-K | — | 2021-03-11 | — | |
| 8-K | — | 2021-03-03 | — | |
| S-3 | — | 2021-02-09 | — |
Showing 101–150 of 202 filings
Key facts
CIK
1434647
CUSIP
488445206
13F (30d)
22 filings
22 filers
Visit website
Investor relations